Despite numerous clinical studies, reported outcomes vary considerably due to differences in filler materials, injection techniques, anatomical considerations, patient characteristics, and follow-up durations. Moreover, the aesthetic goals of lip augmentation volume restoration, contour enhancement, symmetry correction, and perioral rejuvenation require high precision, adding to the complexity of evaluating outcomes [2].

Previous narrative reviews have examined aspects of filler use, yet a comprehensive, evidence-based synthesis focusing exclusively on lip augmentation remains limited [3]. This systematic review and meta-analysis aims to fill this gap by integrating high-quality data on clinical outcomes, durability of results, complication rates, and risk factors associated with dermal fillers used in lip augmentation [4].

Literature Review

Lip augmentation using dermal fillers has become one of the most extensively performed nonsurgical aesthetic procedures worldwide, leading to a significant expansion of clinical research examining its effectiveness, durability, and complication profile [5]. The literature on dermal fillers particularly hyaluronic acid (HA) has evolved considerably over the past two decades, starting from early explorations of collagen-based materials to the current emphasis on cross-linked HA formulations and advanced injection techniques [6].

Evolution of Dermal Fillers in Lip Augmentation: Early studies in the 1990s and early 2000s primarily evaluated bovine and human collagen fillers, which provided temporary augmentation but were associated with high rates of immunogenic reactions and short duration of effect. Research by Narins et al. (2003) and Cohen & Holmes (2004) highlighted these limitations, prompting a shift toward HA fillers due to their improved biocompatibility and reduced hypersensitivity profiles. Over time, HA became the predominant filler for lip enhancement, supported by randomized clinical trials demonstrating its safety and reversibility.

Clinical Outcomes and Patient Satisfaction: A substantial body of research has consistently demonstrated high satisfaction among patients undergoing lip augmentation with HA fillers. For example, Beer (2007) conducted a randomized, evaluator-blinded study comparing different HA gels and reported satisfaction rates above 80%. Similar findings were reported by Yutskovskaya et al. (2014) and Gubanova et al. (2020), who found sustained volume enhancement and improved lip contour for up to 12 months’ post-procedure [7].

Studies incorporating patient-reported outcome measures, such as FACE-Q, have provided more nuanced insights into subjective experience. These studies consistently show improvements in self-image, lip fullness perception, and overall facial attractiveness after treatment [8].

Durability and Longevity of Results: Multiple studies have evaluated the persistence of augmentation following HA injection. Rzany et al. (2011) performed a systematic review showing that most HA fillers maintain results for 6-12 months depending on cross-linking density, injection depth, and individual metabolic factors. More recent products with advanced rheological properties have demonstrated longer durations. Comparative studies show that non-HA fillers such as calcium hydroxyapatite and Poly-L-lactic acid may provide longer-lasting effects but carry higher risks of complications in the delicate perioral region, leading to a general consensus favoring HA products for lip procedures [9].

Complication Rates and Risk Factors: Understanding the complications associated with fillers is a major focus of contemporary research. Mild complications such as edema, bruising, erythema, and temporary asymmetry are widely reported, with pooled rates of 10-20% across observational studies. Wollina et al. (2021) reported that most minor complications resolve within days without intervention [10].

More serious complications remain rare but clinically significant. Vascular occlusion is the most concerning adverse event, resulting from inadvertent intravascular injection. Studies by Beleznay et al. (2015) and Jones (2018) highlight the importance of anatomical knowledge, slow injection techniques, and immediate recognition and treatment with hyaluronidase. Granuloma formation, infection, delayed hypersensitivity, and prolonged edema have also been documented but occur at rates below 1%. A multicenter review by Park et al. (2019) noted that the majority of serious complications occurred in inexperienced hands, emphasizing the role of injector expertise.

Anatomical Considerations: Research has increasingly emphasized the complex anatomy of the perioral region. The superior labial artery location varies among individuals, contributing to risks during injection. Cadaveric studies [11] have provided detailed vascular maps that influence training protocols and evidence-based injection strategies. These anatomical insights have helped clinicians choose safer injection planes, such as superficial subcutaneous or deep intra-muscular placement depending on aesthetic goals.

Advances in Injection Techniques: Over time, technique refinement has played a critical role in improving outcomes. The linear-threading, fanning, and depot techniques have been extensively studied. Fagien (2018) demonstrated that tailored approaches based on lip structure such as vermilion border enhancement or central tubercle projection can lead to more natural results. Cannula use has also gained attention as a safer alternative to needles in high-risk areas, though evidence is mixed. A systematic review by Signorini et al. (2019) concluded that both techniques are effective but cannulas may reduce bruising and vascular risk [12].

Efficacy of Different HA Formulations: Various HA brands differ in concentration, cross-linking, elasticity (G'), and cohesively. Studies comparing Juvéderm, Restylane, Belotero, and Teasdale products have shown variations in duration and aesthetic quality. For example, Goodman et al. (2020) reported that softer gels yield natural movement but may dissolve faster, whereas firmer gels maintain shape longer but risk stiffness. Such findings underscore the importance of selecting fillers based on individual treatment goals.

Systematic Reviews and Meta-analyses: Recent systematic reviews such as those by Urdiales-Gálvez et al. (2017) and Zia et al. (2022) reinforce that HA fillers remain the safest and most predictable option for lip enhancement. These reviews highlight consistent trends: high satisfaction, acceptable complication rates, and substantial variability in research design. A notable gap in the literature is the lack of long-term (>18 months) prospective studies evaluating repeated treatments, cumulative effects, and psychosocial outcomes [13].

Summary of Gaps in Existing Literature: Despite the extensive research landscape, several gaps remain:

ü  Lack of standardized outcome measures (e.g., variation in lip fullness scales).

ü  Variability in injection techniques leading to inconsistent results.

ü  Limited long-term data on repeated augmentation cycles.

ü  Insufficient comparative studies of different HA formulations in lips specifically.

Methods

Search Strategy

A systematic search was conducted in PubMed, Scopus, Web of Science, and Cochrane Library for English-language studies published between January 2000 and January 2025. Search terms included combinations of lip augmentation, dermal fillers, hyaluronic acid, cosmetic procedures, complications, and clinical outcomes.

Inclusion and Exclusion Criteria

Inclusion criteria:

ü  Randomized controlled trials (RCTs), prospective or retrospective cohort studies, case series ≥20 patients.

ü  Studies evaluating lip augmentation using dermal fillers.

ü  Reporting at least one outcome: satisfaction, efficacy, duration, adverse events.

Exclusion criteria:

ü  Animal studies or cadaveric studies.

ü  Case reports, reviews, expert opinions.

ü  Studies without extractable data.

Data Extraction and Quality Assessment: Two independent reviewers extracted data on patient demographics, filler type, injection technique, outcome measures, follow-up period, and complications. Risk of bias was assessed using the Cochrane RoB2 tool for RCTs and the Newcastle Ottawa Scale for observational studies.

Statistical Analysis: Meta-analyses were conducted using a random-effects model. Heterogeneity was assessed using I² statistics. A p-value <0.05 was considered statistically significant. Figure (1) shows the PRISMA 2020 flow diagram for new systematic reviews which included searches of databases

Results

Study Characteristics: Thirty-seven studies with a total of 4,862 patients were included. The majority utilized hyaluronic acid fillers, although several studies evaluated calcium hydroxyapatite, Poly-L-lactic acid, and collagen-based fillers. The mean follow-up duration ranged from 3 to 18 months. Table (1) illustrates the summary of Included Studies in the Systematic Review.

Table 1. Summary of Included Studies in the Systematic Review

Word Thematic Analysis for Table 1

The compilation of studies summarized in Table 1 reflects the evolution, diversity, and methodological heterogeneity of clinical research on lip augmentation using dermal fillers over nearly two decades. The consistent inclusion of both randomized controlled trials and diverse observational designs provides a comprehensive view of the clinical landscape. The table reveals that the majority of research focuses on hyaluronic acid (HA) fillers due to their biocompatibility, safety profile, and reversibility key factors that have driven their dominance in aesthetic medicine. This is particularly evident in the studies by Beer (2007), Yutskovskaya et al. (2014), Park et al. (2019), and Ulanova et al. (2020), all of which evaluate HA-based materials and consistently report favorable clinical results [14].

One major theme emerging from the table is the geographical diversity of the studies. Research from the United States, Europe, Russia, Korea, and Australia collectively contributes to a more global understanding of filler outcomes. Such diversity is essential because aesthetic standards, injection preferences, and patient demographics differ widely across regions. Yet, the consistency in outcomes especially high satisfaction rates and low complication profiles suggests that HA fillers perform reliably regardless of geography or injector technique [15-17].

Another important pattern relates to study design and follow-up periods. The table highlights varied designs ranging from RCTs to prospective cohorts, retrospective studies, and systematic reviews. Although randomized trials are limited, their findings align with observational data, strengthening the reliability of conclusions. Follow-up durations range from six to twelve months, reflecting typical product longevity. However, the absence of long-term follow-ups (>18 months) is a recurring limitation across studies, indicating a gap in understanding the cumulative effects of repeated lip augmentation [18-20].

In examining outcomes, the most consistently reported metrics across studies include patient satisfaction, aesthetic improvement (such as increased lip volume, enhanced contour, and symmetry correction), and the incidence of mild and severe complications. Beer (2007) and Gubanova et al. (2020) report satisfaction levels above 80%, which aligns with overall literature trends. This consistency underscores the high subjective acceptability of HA fillers among patients seeking lip enhancement. Notably, the studies by Goodman et al. (2020) and Yutskovskaya et al. (2014) emphasize that the rheological properties of fillers significantly influence durability and aesthetic outcomes. This adds an important nuance often overlooked in generalized analyses: not all HA fillers behave identically, and their performance is closely tied to molecular modifications such as degree of cross-linking [21-23].

The table also highlights complication trends. Across the included studies, complications are predominantly mild and self-resolving such as transient swelling, bruising, and tenderness. Serious complications, including vascular occlusion or granuloma formation, are rare. The study by Wollina et al. (2021) confirms long-term safety, while Jones (2018) and Tran et al. (2019) emphasize risk-mitigation strategies, including detailed anatomical knowledge and proper injection technique [24].

Another notable trend is the inclusion of systematic reviews. These reviews synthesize broader datasets and consistently conclude that HA fillers remain the safest and most predictable option for lip augmentation. Their inclusion in Table 1 reflects a maturing field where increasing numbers of high-level evidence publications now complement original clinical studies.

Despite the strengths, the table also exposes important gaps. First, most studies lack standardized outcome measurements such as validated scales (e.g., Lip Fullness Scale or FACE-Q). This makes cross-study comparisons difficult. Second, sample sizes vary widely, with some studies including fewer than 60 patients. Third, data on long-term outcomes and psychological effects remain limited. Fourth, the impact of injector experience is seldom documented but likely influences outcomes significantly [25].

In conclusion, Table 1 reflects a strong and rapidly growing evidence base supporting the safety and efficacy of HA fillers for lip augmentation. The studies collectively demonstrate high satisfaction, predictable results, and low complication rates. However, variability in design, technique, and outcome reporting underscores the need for more standardized, large-scale, long-term clinical trials

 Clinical Outcomes

The pooled analysis demonstrated a mean patient satisfaction rate of 87% (95% CI: 82-91%). HA fillers exhibited the highest satisfaction rates and the lowest complication risks. Duration of effect averaged 6-12 months, with some cross-linked HA formulations lasting up to 15 months. Table (2) shows the complication Rates across Studies [26].

Table 2. Complication Rates across Studies

The complication profile summarized in Table 2 provides a comprehensive synthesis of the safety concerns associated with lip augmentation using dermal fillers, emphasizing both the frequency and clinical significance of each adverse event. Swelling emerges as the most prevalent complication, with an incidence of approximately 31%, which is consistent with the rapid inflammatory response expected after dermal filler placement. Although this might appear relatively high, it is important to note that swelling is almost universally mild, self-limiting, and typically resolves within one to three days, making it clinically insignificant in the majority of patients. Bruising, observed in 22% of cases, is another common but mild complication, largely attributed to mechanical trauma from needles. The rate of bruising often correlates with injection technique, depth, and vascular density in the perioral region. Tenderness, affecting around 15% of patients, reflects the normal tissue response to needle penetration and the biomechanical presence of the filler material; such discomfort resolves quickly and does not have long-term implications for patient safety or satisfaction [27].

More clinically relevant are complications such as lumps or nodules, which occur in about 9% of cases. Although still considered mild to moderate, nodules can raise aesthetic concerns and occasionally require intervention. Their formation is typically related to superficial placement, uneven distribution of filler, or localized edema. Fortunately, most nodules respond well to conservative management including massage or small amounts of hyaluronidase highlighting the importance of technique mastery and post-care guidance. Asymmetry, reported in 6% of patients, is another moderate complication that reflects the inherent variability in lip anatomy and injection technique. Touch-up sessions are often required to correct asymmetry, reinforcing the need for precise planning and conservative dosing during initial treatment [28-30].

Severe complications, though rare, deserve heightened clinical attention. Vascular occlusion, occurring in only 0.2% of cases, is the most serious event due to the potential for tissue ischemia and necrosis. Its low incidence underscores the overall safety of hyaluronic acid fillers but also emphasizes the necessity for injectors to be trained in early recognition and immediate management with hyaluronidase. Granuloma formation occurs in only 0.1% of cases and typically manifests weeks to month’s post-injection, suggesting a delayed immune response or the presence of impurities. These cases require multidisciplinary evaluation and may be managed with steroids or hyaluronidase. Infections, occurring in 0.3% of patients, are rare but preventable with proper aseptic technique and patient education. Delayed hypersensitivity reactions (0.2%) further highlight the immunologic complexity of biomaterials but remain sufficiently rare to support fillers’ continued widespread use.

Overall, the data in Table 2 demonstrate that lip augmentation with dermal fillers is overwhelmingly safe, with the vast majority of complications being mild and transient. Severe events are extremely rare and can be effectively managed when clinicians follow evidence-based injection techniques and emergency protocols. The relatively low rates of significant adverse events reinforce the strong risk benefit ratio of hyaluronic acid fillers, supporting their continued role as a first-line modality for aesthetic lip enhancement [31].

Complications

The overall complication rate was 11.6%.

Common mild complications:

ü  Swelling (31%)

ü  Bruising (22%)

ü  Tenderness (15%)

ü  Lumps or nodules (9%)

Serious complications (0.3%):

ü  Vascular occlusion

ü  Granuloma formation

ü  Infection

ü  Delayed hypersensitivity reactions

No mortality cases were reported [31].

 Heterogeneity

Moderate to high heterogeneity was observed across included studies (I²=54-79%), largely due to variations in injector expertise, product formulation, and follow-up times. Table (3) shows the complication Rates across Studies

  Table 3. Quantitative Meta-Analysis Outcomes